这是一篇来自已证抗体库的有关人类 CD38的综述,是根据252篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD38 抗体。
CD38 同义词: ADPRC 1; ADPRC1

BioLegend
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD38抗体(BioLegend, 303510)被用于被用于流式细胞仪在人类样本上 (图 1c). Sci Adv (2022) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s16
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s16). Mol Ther Methods Clin Dev (2022) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 s4a
BioLegend CD38抗体(Biolegend, 303535)被用于被用于mass cytometry在人类样本上 (图 s4a). Biomark Res (2022) ncbi
小鼠 单克隆(HIT2)
  • 其他; 人类; 图 s3
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于其他在人类样本上 (图 s3). Cancers (Basel) (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:400
BioLegend CD38抗体(BioLegend, 303516)被用于被用于流式细胞仪在人类样本上浓度为1:400. Cell (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. Adv Sci (Weinh) (2021) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 5a
BioLegend CD38抗体(Biolegend, 356616)被用于被用于流式细胞仪在人类样本上 (图 5a). J Clin Invest (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3b
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3b). Acta Neuropathol (2021) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD38抗体(BioLegend, 356604)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Clin Cancer Res (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. Immunity (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:1000; 图 1e
BioLegend CD38抗体(Biolegend, 303509)被用于被用于流式细胞仪在人类样本上浓度为1:1000 (图 1e). Cell (2021) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HB7)被用于被用于流式细胞仪在人类样本上. EMBO Mol Med (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). elife (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4b
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4b). Cell Death Dis (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 2s1b
BioLegend CD38抗体(Biolegend, 303510)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2s1b). elife (2019) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD38抗体(Biolegend, 356620)被用于被用于流式细胞仪在人类样本上 (图 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:200; 图 s10b
BioLegend CD38抗体(Biolegend, 303524)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s10b). Science (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 7b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 7b). J Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s5). Nature (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:40; 图 5b
BioLegend CD38抗体(Biolegend, 303508)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 5b). Nat Commun (2019) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD38抗体(Biolegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 1d). Front Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(BioLegend, 303532)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell (2019) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 3g
BioLegend CD38抗体(BioLegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 3g). Sci Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 2b
BioLegend CD38抗体(Biolegend, 303502)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2b
BioLegend CD38抗体(Biolegend, 303518)被用于被用于流式细胞仪在人类样本上 (图 2b). Nature (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s1a). Cell Stem Cell (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s6d
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s6d). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD38抗体(Biolegend, 303502)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s8a
BioLegend CD38抗体(BioLegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s8a). Leukemia (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD38抗体(Biolegend, 303532)被用于被用于流式细胞仪在人类样本上 (图 s5). J Clin Invest (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD38抗体(BioLegend, 356618)被用于被用于流式细胞仪在人类样本上 (图 7a). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2e
BioLegend CD38抗体(BioLegend, 303515)被用于被用于流式细胞仪在人类样本上 (图 s2e). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s7g
BioLegend CD38抗体(BioLegend, 303512)被用于被用于流式细胞仪在人类样本上 (图 s7g). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD38抗体(Biolegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Cell Sci (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2d
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2d). J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s3
BioLegend CD38抗体(biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s3). Cell (2017) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 s3a
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD38抗体(BioLegend, 303510)被用于被用于流式细胞仪在人类样本上 (图 1b). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 s8
BioLegend CD38抗体(BioLegend, 303502)被用于被用于mass cytometry在人类样本上 (图 s8). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s2
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s2). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(biolegend, HIT-2)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 2d
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Clin Invest (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1b). Cell Transplant (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(HB-7)
BioLegend CD38抗体(Biolegend, 356608)被用于. Nat Commun (2016) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s4
BioLegend CD38抗体(Biolegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(BioLegend, 303509)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s1). Analyst (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图  4
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图  4). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
BioLegend CD38抗体(BIOLEGEND, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 人类; 图 1
BioLegend CD38抗体(BioLegend, 303509)被用于被用于免疫细胞化学在人类样本上 (图 1). Leukemia (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:80
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:80. J Immunol Methods (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 5). J Exp Med (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
BioLegend CD38抗体(Biolegend, # 303515)被用于被用于流式细胞仪在人类样本上 (图 5). Biomaterials (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Int Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). J Autoimmun (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). Cytokine (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). Immunol Cell Biol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, 303506)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(BioLegend, HIT-2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
赛默飞世尔
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5g
赛默飞世尔 CD38抗体(eBioscience, 12-0389-42)被用于被用于流式细胞仪在人类样本上 (图 5g). Sci Transl Med (2022) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 1e-h
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 1e-h). Adv Sci (Weinh) (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5b
赛默飞世尔 CD38抗体(Thermo Fisher Scientific, HIT2)被用于被用于流式细胞仪在人类样本上 (图 5b). ACS Synth Biol (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, 17-0389-42)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Med (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:1200; 图 1a
赛默飞世尔 CD38抗体(eBioscience, 25-0389-42)被用于被用于流式细胞仪在人类样本上浓度为1:1200 (图 1a). elife (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD38抗体(Thermo Fisher Scientific, 25-0389-42)被用于被用于流式细胞仪在人类样本上 (图 2a). Sci Rep (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔 CD38抗体(Thermo Fisher, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Clin Invest (2018) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 7a
赛默飞世尔 CD38抗体(eBioscience, 85-25-0388-41)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 7a). J Clin Invest (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). Arthritis Rheumatol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 8
赛默飞世尔 CD38抗体(eBioscience, 17-0389)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 8). Haematologica (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD38抗体(eBioscience, 25-0389)被用于被用于流式细胞仪在人类样本上 (图 1c). Haematologica (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD38抗体(ThermoFisher, MHCD3817)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1c). PLoS Pathog (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 4j
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 4j). Nat Chem Biol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(e-bioscience, HIT-2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nat Med (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(38C03 (SPC32))
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD38抗体(Labvision, 38C03)被用于被用于免疫组化-石蜡切片在人类样本上. Arthritis Res Ther (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Invitrogen, MHCD3805)被用于被用于流式细胞仪在人类样本上. Oncotarget (2013) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Immunology (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(38C03 (SPC32))
  • 免疫组化-石蜡切片; 人类; 1:50; 表 2
赛默飞世尔 CD38抗体(Neomarkers, 38C03)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 2). PLoS ONE (2012) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(Invitrogen, MHCD3817)被用于被用于流式细胞仪在人类样本上 (图 4). Nat Genet (2012) ncbi
小鼠 单克隆(AT13/5)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD38抗体(NeoMarker, AT1)被用于被用于免疫组化-石蜡切片在人类样本上. Diagn Pathol (2011) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1d
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1d). Nat Protoc (2008) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Arthritis Rheum (2008) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag Laboratories, HB-7)被用于被用于流式细胞仪在人类样本上. J Immunol (2008) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Leukemia (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Caltag-Medsystems, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Leuk Res (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上 (表 1). Haematologica (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1A
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1A). J Transl Med (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2005) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, MHCD3801)被用于被用于流式细胞仪在人类样本上. Haematologica (2003) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT-2)被用于被用于流式细胞仪在人类样本上. J Virol (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(Caltag Laboratories, clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(Caltag, Clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). Br J Haematol (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Hematol (2000) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (2000) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 5). Photochem Photobiol (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Bone Marrow Transplant (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). J Exp Med (1997) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (1995) ncbi
圣克鲁斯生物技术
小鼠 单克隆(H-11)
  • 免疫组化-冰冻切片; 大鼠; 1:25; 图 3a
  • 免疫印迹; 大鼠; 1:100; 图 2c
圣克鲁斯生物技术 CD38抗体(Santa Cruz, sc-374650)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:25 (图 3a) 和 被用于免疫印迹在大鼠样本上浓度为1:100 (图 2c). Front Pharmacol (2022) ncbi
安迪生物R&D
小鼠 单克隆(240742)
  • 流式细胞仪; 人类; 1:200; 图 4f
安迪生物R&D CD38抗体(R&D Systems, FAB2404P)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 4f). Nat Neurosci (2022) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR4106)
  • 免疫组化-石蜡切片; 人类; 表 s7
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, EPR4106)被用于被用于免疫组化-石蜡切片在人类样本上 (表 s7). Cell (2017) ncbi
小鼠 单克隆(FS02)
  • 免疫印迹; 小鼠; 1:1000; 图 5e
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, ab1173)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5e). Mol Biol Cell (2016) ncbi
domestic rabbit 单克隆(EPR4106)
  • 免疫细胞化学; 人类; 1:100; 图 3
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, ab108403)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3). Lab Chip (2015) ncbi
美天旎
人类 单克隆(REA572)
  • 流式细胞仪; 人类; 图 3d
美天旎 CD38抗体(Miltenyi Biotec, REA572)被用于被用于流式细胞仪在人类样本上 (图 3d). N Biotechnol (2018) ncbi
小鼠 单克隆(IB6)
  • 流式细胞仪; 人类; 图 4c
美天旎 CD38抗体(Miltenyi Biotec, IB6)被用于被用于流式细胞仪在人类样本上 (图 4c). Int J Mol Sci (2017) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类; 1:20; 图 2
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 2). elife (2020) ncbi
小鼠 单克隆(T16)
  • 流式细胞仪; 人类; 图 1b
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, T16)被用于被用于流式细胞仪在人类样本上 (图 1b). Blood (2017) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类; 图 2a
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类; 1:25; 图 2
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(T16)
  • 其他; 人类; 200 ug/ml; 图 3
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, IM0366)被用于被用于其他在人类样本上浓度为200 ug/ml (图 3). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(T16)
  • 流式细胞仪; 人类; 表 4
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, T16)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman-Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
Stemcell Technologies
小鼠 单克隆(AT-1)
  • 流式细胞仪; African green monkey; 图 5c
干细胞技术 CD38抗体(干细胞, 60131FI)被用于被用于流式细胞仪在African green monkey样本上 (图 5c). PLoS Pathog (2020) ncbi
小鼠 单克隆(AT-1)
  • 流式细胞仪; 猕猴; 1:200; 图 3g
干细胞技术 CD38抗体(干细胞技术, 60131FI)被用于被用于流式细胞仪在猕猴样本上浓度为1:200 (图 3g). Nature (2019) ncbi
Cytognos
单克隆(LD38)
  • 流式细胞仪; 人类; 表 1
Cytognos CD38抗体(Cytognos, LD38)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
碧迪BD
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2i, s6g
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2i, s6g). Nat Commun (2022) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 e5b
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 e5b). Nature (2022) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5l
碧迪BD CD38抗体(BD Bioscience, 560981)被用于被用于流式细胞仪在人类样本上 (图 s5l). J Exp Med (2022) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, 551400)被用于被用于流式细胞仪在人类样本上. Signal Transduct Target Ther (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:400; 图 s2c
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:400 (图 s2c). Nature (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s3). Cancers (Basel) (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:500; 图 3c
碧迪BD CD38抗体(BD Horizon, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:500 (图 3c). Nature (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:200; 图 s1h
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1h). Nature (2021) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD38抗体(BD Biosciences, 551400)被用于被用于流式细胞仪在人类样本上 (图 5a). elife (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, 560982)被用于被用于流式细胞仪在人类样本上. J Clin Invest (2020) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, 335790)被用于被用于流式细胞仪在人类样本上. J Clin Invest (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). Science (2020) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 500 ug/ml; 图 s11a
碧迪BD CD38抗体(BD, HIT2)被用于被用于mass cytometry在人类样本上浓度为500 ug/ml (图 s11a). Nature (2020) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s10b
碧迪BD CD38抗体(BD Biosciences, 555462)被用于被用于流式细胞仪在人类样本上 (图 s10b). Nat Commun (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD38抗体(BD Pharmingen, 560982)被用于被用于流式细胞仪在人类样本上 (图 1b). Sci Rep (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:10; 图 2f
碧迪BD CD38抗体(BD, 347687)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 2f). Nature (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s7b
碧迪BD CD38抗体(BD Biosciences, 555462)被用于被用于流式细胞仪在人类样本上 (图 s7b). Mol Cell (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD38抗体(BD Biosciences, 347687)被用于被用于流式细胞仪在人类样本上 (图 s1b). Cell (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 1a). Blood Cancer J (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 4b
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 4b). Nat Commun (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD Horizon, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2c). Sci Rep (2018) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 小鼠; 图 3c
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在小鼠样本上 (图 3c). Sci Rep (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, 555462)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2018) ncbi
小鼠 单克隆(HB7)
碧迪BD CD38抗体(BD Biosciences, HB7)被用于. Cell Stem Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, 555460)被用于被用于流式细胞仪在人类样本上 (图 2a). J Virol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, 562445)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s7j
碧迪BD CD38抗体(BD, 555462)被用于被用于流式细胞仪在人类样本上 (图 s7j). Nat Med (2018) ncbi
小鼠 单克隆(22/CD38)
  • 免疫印迹基因敲除验证; 人类; 图 2d
碧迪BD CD38抗体(Becton Dickinson, 611114)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 2d). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(Becton Dickinson, 555460)被用于被用于流式细胞仪在人类样本上 (图 3a). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:10; 图 s2
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 其他; 人类; 图 s1
  • 酶联免疫吸附测定; 人类; 图 st2
碧迪BD CD38抗体(BD/Pharm, 555458)被用于被用于其他在人类样本上 (图 s1) 和 被用于酶联免疫吸附测定在人类样本上 (图 st2). Cell Chem Biol (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Pharmingen, 335808)被用于被用于流式细胞仪在人类样本上 (图 s2). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s9
碧迪BD CD38抗体(BD, 555461)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(Pharmingen, HB7)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Bioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD Bioscience, 345806)被用于被用于流式细胞仪在人类样本上 (图 4a). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2c). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:200; 图 s1c
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1c). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s12b
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s12b). J Clin Invest (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 e7a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 e7a). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3c). J Biol Chem (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD, 562288)被用于被用于流式细胞仪在人类样本上 (图 4a). J Virol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a, s4
碧迪BD CD38抗体(BD Biosciences, 562444)被用于被用于流式细胞仪在人类样本上 (图 1a, s4). JCI Insight (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1a, s4
碧迪BD CD38抗体(BD Biosciences, 335790)被用于被用于流式细胞仪在人类样本上 (图 1a, s4). JCI Insight (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD38抗体(BD Biosciences, 551400)被用于被用于流式细胞仪在人类样本上 (图 st1). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nat Commun (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 st9
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, 340926)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 3a). Angiogenesis (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50; 图 1
碧迪BD CD38抗体(BD, 555462)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s2). Sci Rep (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(Becton Dickinson, 551400)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 5f
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 5f). Nat Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1b
碧迪BD CD38抗体(BD, 560677)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1b). Nat Cell Biol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
  • 免疫细胞化学; 人类; 图 4
碧迪BD CD38抗体(BD, HIT-2)被用于被用于流式细胞仪在人类样本上 (图 1) 和 被用于免疫细胞化学在人类样本上 (图 4). JCI Insight (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 e1c
碧迪BD CD38抗体(BD biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 e1c). Nature (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 1b). Cancer Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s2). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2d
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s2d). J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 9a
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (图 9a). J Exp Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s4). Oncotarget (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; baboons; 图 5
碧迪BD CD38抗体(Pharmingen, 561106)被用于被用于流式细胞仪在baboons样本上 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 7c
  • 流式细胞仪; 小鼠; 图 7d
碧迪BD CD38抗体(BD Biosciences, 562444)被用于被用于流式细胞仪在人类样本上 (图 7c) 和 被用于流式细胞仪在小鼠样本上 (图 7d). J Biol Chem (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:20; 图 1
碧迪BD CD38抗体(BD Pharmingen, 555461)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD38抗体(BD, 555460)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD38抗体(BD, 555459)被用于被用于流式细胞仪在人类样本上 (图 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 7c
碧迪BD CD38抗体(Becton Dickinson, 345806)被用于被用于流式细胞仪在人类样本上 (图 7c). BMC Biotechnol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD38抗体(BD Pharmingen, BD555459)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HB7)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s1a, s1b, s1c
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上 (图 s1a, s1b, s1c). Science (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, # 555462)被用于被用于流式细胞仪在人类样本上. Immunol Res (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD38抗体(BD Biosciences, 563965)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, 555460)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(22/CD38)
  • 免疫印迹; 人类
碧迪BD CD38抗体(BD Pharmingen, 611114)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS Negl Trop Dis (2015) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 人类; 图 6
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于免疫细胞化学在人类样本上 (图 6). Oncogene (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD Bioscience, 560677)被用于被用于流式细胞仪在人类样本上 (图 1). J Hematol Oncol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, 555458)被用于被用于流式细胞仪在人类样本上. MAbs (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s3). J Immunol (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:100
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上浓度为1:100. Cell Stem Cell (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 6). Am J Hum Genet (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Blood (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 st3). AIDS (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD38抗体(BD Bioscience, HB7)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 4 ul/test
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上浓度为4 ul/test. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 小鼠
碧迪BD CD38抗体(PharMingen, HIT2)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上. FASEB J (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD, HB-7)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2a). Blood (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB-7)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, clone HB7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上. Genes Dev (2009) ncbi
文章列表
  1. Dr xe4 ger N, Sattler S, Huang C, Teter O, Leng K, Hashemi S, et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat Neurosci. 2022;25:1149-1162 pubmed 出版商
  2. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed 出版商
  3. Hannawi Y, Ewees M, Moore J, Zweier J. Characterizing CD38 Expression and Enzymatic Activity in the Brain of Spontaneously Hypertensive Stroke-Prone Rats. Front Pharmacol. 2022;13:881708 pubmed 出版商
  4. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed 出版商
  5. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed 出版商
  6. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed 出版商
  7. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed 出版商
  8. Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa C, Chen C, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci Transl Med. 2022;14:eabe8195 pubmed 出版商
  9. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed 出版商
  10. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed 出版商
  11. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed 出版商
  12. Lejeune M, Duray E, Peipp M, Clémenceau B, Baron F, Beguin Y, et al. Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers (Basel). 2021;13: pubmed 出版商
  13. Amanat F, Thapa M, Lei T, Ahmed S, Adelsberg D, Carreño J, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. 2021;184:3936-3948.e10 pubmed 出版商
  14. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed 出版商
  15. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed 出版商
  16. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed 出版商
  17. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed 出版商
  18. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed 出版商
  19. Hirano M, Imai Y, Kaito Y, Murayama T, Sato K, Ishida T, et al. Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma. J Exp Clin Cancer Res. 2021;40:110 pubmed 出版商
  20. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed 出版商
  21. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed 出版商
  22. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed 出版商
  23. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed 出版商
  24. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed 出版商
  25. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed 出版商
  26. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed 出版商
  27. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed 出版商
  28. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed 出版商
  29. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed 出版商
  30. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed 出版商
  31. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed 出版商
  32. Delgobo M, Mendes D, Kozlova E, Rocha E, Rodrigues Luiz G, Mascarin L, et al. An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. elife. 2019;8: pubmed 出版商
  33. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed 出版商
  34. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed 出版商
  35. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed 出版商
  36. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  37. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed 出版商
  38. Nam A, Kim K, Chaligne R, Izzo F, Ang C, Taylor J, et al. Somatic mutations and cell identity linked by Genotyping of Transcriptomes. Nature. 2019;571:355-360 pubmed 出版商
  39. Hill D, Pierson W, Bolland D, Mkindi C, Carr E, Wang J, et al. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes. J Exp Med. 2019;: pubmed 出版商
  40. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed 出版商
  41. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed 出版商
  42. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed 出版商
  43. Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951 pubmed 出版商
  44. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed 出版商
  45. Moffett H, Harms C, Fitzpatrick K, Tooley M, Boonyaratanakornkit J, Taylor J. B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4: pubmed 出版商
  46. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  47. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  48. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed 出版商
  49. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed 出版商
  50. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  51. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed 出版商
  52. Lu E, Wolfreys F, Muppidi J, Xu Y, Cyster J. S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature. 2019;: pubmed 出版商
  53. van Galen P, Hovestadt V, Wadsworth Ii M, Hughes T, Griffin G, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176:1265-1281.e24 pubmed 出版商
  54. Kriegsmann K, Baertsch M, Awwad M, Merz M, Hose D, Seckinger A, et al. Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients. Blood Cancer J. 2019;9:13 pubmed 出版商
  55. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed 出版商
  56. Ge Y, Schuster M, Pundhir S, Rapin N, Bagger F, Sidiropoulos N, et al. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia. Nat Commun. 2019;10:172 pubmed 出版商
  57. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed 出版商
  58. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed 出版商
  59. Al Maskari M, Care M, Robinson E, Cocco M, Tooze R, Doody G. Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Sci Rep. 2018;8:14338 pubmed 出版商
  60. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed 出版商
  61. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  62. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  63. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  64. Heshmati Y, Kharazi S, Türköz G, Chang D, Kamali Dolatabadi E, Boström J, et al. The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation. Sci Rep. 2018;8:11202 pubmed 出版商
  65. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed 出版商
  66. Weniger M, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest. 2018;128:2996-3007 pubmed 出版商
  67. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed 出版商
  68. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed 出版商
  69. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed 出版商
  70. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed 出版商
  71. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed 出版商
  72. Khajuria R, Munschauer M, Ulirsch J, Fiorini C, Ludwig L, McFarland S, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018;173:90-103.e19 pubmed 出版商
  73. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed 出版商
  74. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed 出版商
  75. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed 出版商
  76. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed 出版商
  77. Macdonald R, Shrimp J, Jiang H, Zhang L, Lin H, Yen A. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. Sci Rep. 2017;7:17406 pubmed 出版商
  78. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed 出版商
  79. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed 出版商
  80. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  81. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  82. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  83. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed 出版商
  84. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed 出版商
  85. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  86. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed 出版商
  87. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed 出版商
  88. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed 出版商
  89. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed 出版商
  90. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed 出版商
  91. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  92. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed 出版商
  93. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  94. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed 出版商
  95. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  96. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  97. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed 出版商
  98. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  99. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  100. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  101. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  102. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed 出版商
  103. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed 出版商
  104. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed 出版商
  105. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed 出版商
  106. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  107. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  108. Fatehchand K, McMichael E, Reader B, Fang H, Santhanam R, Gautam S, et al. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656-25666 pubmed
  109. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  110. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  111. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed 出版商
  112. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed 出版商
  113. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  114. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed 出版商
  115. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  116. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed 出版商
  117. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  118. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  119. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  120. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed 出版商
  121. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed 出版商
  122. Nejedlá M, Sadi S, Sulimenko V, de Almeida F, Blom H, Draber P, et al. Profilin connects actin assembly with microtubule dynamics. Mol Biol Cell. 2016;27:2381-93 pubmed 出版商
  123. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  124. Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft L, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128:371-83 pubmed 出版商
  125. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  126. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed 出版商
  127. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  128. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed 出版商
  129. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed 出版商
  130. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed 出版商
  131. Lisenko K, Schonland S, Jauch A, Andrulis M, Rocken C, Ho A, et al. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016;5:1464-72 pubmed 出版商
  132. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  133. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  134. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  135. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed 出版商
  136. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed 出版商
  137. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed 出版商
  138. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed 出版商
  139. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed 出版商
  140. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed 出版商
  141. Lee J, Han A, Lee S, Min W, Kim H. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment. Mol Med Rep. 2016;13:3849-57 pubmed 出版商
  142. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  143. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  144. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  145. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed 出版商
  146. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  147. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed 出版商
  148. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  149. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  150. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  151. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed 出版商
  152. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed 出版商
  153. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed 出版商
  154. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  155. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed 出版商
  156. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  157. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed 出版商
  158. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  159. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed 出版商
  160. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed 出版商
  161. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  162. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed 出版商
  163. Bunaciu R, Jensen H, Macdonald R, Latocha D, Varner J, Yen A. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. PLoS ONE. 2015;10:e0135668 pubmed 出版商
  164. Lorkova L, Scigelova M, Arrey T, Vit O, Pospisilova J, Doktorova E, et al. Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS ONE. 2015;10:e0135314 pubmed 出版商
  165. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed 出版商
  166. Nishioka C, Ikezoe T, Takeuchi A, Nobumoto A, Tsuda M, Yokoyama A. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells. Leukemia. 2015;29:2296-306 pubmed 出版商
  167. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed 出版商
  168. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  169. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  170. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed 出版商
  171. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed 出版商
  172. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  173. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  174. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed 出版商
  175. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  176. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  177. Esch M, Prot J, Wang Y, Miller P, Llamas Vidales J, NAUGHTON B, et al. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip. 2015;15:2269-77 pubmed 出版商
  178. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed 出版商
  179. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed 出版商
  180. Overdijk M, Verploegen S, Bögels M, van Egmond M, Lammerts van Bueren J, Mutis T, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs. 2015;7:311-21 pubmed 出版商
  181. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed 出版商
  182. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed 出版商
  183. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  184. Laurenti E, Frelin C, Xie S, Ferrari R, Dunant C, Zandi S, et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell. 2015;16:302-13 pubmed 出版商
  185. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed 出版商
  186. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  187. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed 出版商
  188. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed 出版商
  189. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  190. Sun W, Wang Y, East J, Kimball A, Tkaczuk K, Kesmodel S, et al. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine. 2015;72:48-57 pubmed 出版商
  191. Bürgler S, Gimeno A, Parente Ribes A, Wang D, Os A, Devereux S, et al. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol. 2015;194:827-35 pubmed 出版商
  192. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed 出版商
  193. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  194. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  195. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  196. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  197. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed 出版商
  198. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed 出版商
  199. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  200. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  201. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  202. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed 出版商
  203. Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed 出版商
  204. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed 出版商
  205. Chiu Y, Lin I, Su S, Wang K, Yang S, Tsai D, et al. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol. 2014;193:2207-17 pubmed 出版商
  206. Kusner L, Ciesielski M, Marx A, Kaminski H, Fenstermaker R. Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS ONE. 2014;9:e102231 pubmed 出版商
  207. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  208. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  209. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  210. Hoermann G, Blatt K, Greiner G, Putz E, Berger A, Herrmann H, et al. CD52 is a molecular target in advanced systemic mastocytosis. FASEB J. 2014;28:3540-51 pubmed 出版商
  211. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed 出版商
  212. Szánthó E, Bhattoa H, Csobán M, Antal Szalmas P, Ujfalusi A, Kappelmayer J, et al. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia. PLoS ONE. 2014;9:e91647 pubmed 出版商
  213. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  214. Mueller A, Brieske C, Schinke S, Csernok E, Gross W, Hasselbacher K, et al. Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Arthritis Res Ther. 2014;16:R55 pubmed 出版商
  215. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  216. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  217. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed 出版商
  218. Martinez Marignac V, Smith S, Toban N, Bazile M, Aloyz R. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget. 2013;4:2550-66 pubmed
  219. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed 出版商
  220. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed 出版商
  221. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  222. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  223. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed 出版商
  224. Manjarrez Orduno N, Marasco E, Chung S, Katz M, Kiridly J, Simpfendorfer K, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet. 2012;44:1227-30 pubmed 出版商
  225. Zuo Z, Tang Y, Bi C, Zhang W, Zhao S, Wang X, et al. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol. 2011;6:123 pubmed 出版商
  226. Doulatov S, Notta F, Rice K, Howell L, Zelent A, Licht J, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 2009;23:2076-87 pubmed 出版商
  227. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed 出版商
  228. Jacobi A, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58:1762-73 pubmed 出版商
  229. Friedrichs B, Siegel S, Kloess M, Barsoum A, Coggin J, Rohrer J, et al. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia. J Immunol. 2008;180:6374-84 pubmed
  230. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  231. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  232. Kolar G, Mehta D, Wilson P, Capra J. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-24 pubmed
  233. Biedermann B, Gil D, Bowen D, Crocker P. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors. Leuk Res. 2007;31:211-20 pubmed
  234. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  235. Timeus F, Crescenzio N, Sanavio F, Fazio L, Doria A, Foglia L, et al. Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice. Haematologica. 2006;91:369-72 pubmed
  236. Ninos J, Jefferies L, Cogle C, Kerr W. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J Transl Med. 2006;4:9 pubmed
  237. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  238. Mateo G, Corral M, Almeida J, López Berges C, Nieto m, García Marcos A, et al. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma. Haematologica. 2003;88:1013-21 pubmed
  239. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  240. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562-71 pubmed
  241. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  242. Lewandowski D, Linassier C, Iochmann S, Degenne M, Domenech J, Colombat P, et al. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells. Br J Haematol. 2002;118:535-44 pubmed
  243. Zhang X, Dormady S, Basch R. Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors. Exp Hematol. 2000;28:1286-96 pubmed
  244. Barquinero J, Segovia J, Ramirez M, Limon A, Guenechea G, Puig T, et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood. 2000;95:3085-93 pubmed
  245. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  246. Grammer A, McFarland R, Heaney J, Darnell B, Lipsky P. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol. 1999;163:4150-9 pubmed
  247. Denning Kendall P, Horsley H, Donaldson C, Bradley B, Hows J. Different behaviour of fresh and cultured CD34+ cells during immunomagnetic separation. Br J Haematol. 1999;105:780-5 pubmed
  248. Luque R, Brieva J, Moreno A, Manzanal A, Escribano L, Villarrubia J, et al. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. Clin Exp Immunol. 1998;112:410-8 pubmed
  249. Hryhorenko E, Rittenhouse Diakun K, Harvey N, Morgan J, Stewart C, Oseroff A. Characterization of endogenous protoporphyrin IX induced by delta-aminolevulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry. Photochem Photobiol. 1998;67:565-72 pubmed
  250. Denning Kendall P, Nicol A, Horsley H, Donaldson C, Bradley B, Hows J. Is in vitro expansion of human cord blood cells clinically relevant?. Bone Marrow Transplant. 1998;21:225-32 pubmed
  251. van der Voort R, Taher T, Keehnen R, Smit L, Groenink M, Pals S. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med. 1997;185:2121-31 pubmed
  252. Muench M, Roncarolo M, Menon S, Xu Y, Kastelein R, Zurawski S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 1995;85:963-72 pubmed